Glenmark receives approval from the CDSCO Panel to study the FDC drug imetasone furoate, glycopyrrolate, and indacaterol.

Published Date: 24 Jul 2023

The Subject Expert Committee (SEC), which is part of the Central Drug Standard Control, has given the drug manufacturer Glenmark the green light.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot